Long COVID, audiovestibular symptoms and persistent chemosensory dysfunction: a systematic review of the current evidence | ACTA Otorhinolaryngologica Italica
Long Covid and diet
Mechanism of Anosmia Caused by Symptoms of COVID-19 and Emerging Treatments | ACS Chemical Neuroscience
Anosmia: how Covid brought loss of smell centre stage | Medical research | The Guardian
Perdita dell'olfatto e del gusto: semplice raffreddore o Covid19?
Management of new onset anosmia during the COVID pandemic - BRS Consensus Guidelines - Authorea
Pathophysiology and possible treatments for olfactory-gustatory disorders in patients affected by COVID-19 - ScienceDirect
Diseases | Free Full-Text | Post-COVID-19 Anosmia and Therapies: Stay Tuned for New Drugs to Sniff Out
Potential of Omega 3 Supplementation for Coronavirus Disease | IJGM
Can Omega-3 Fatty Acid Supplementation Treat Anosmia? - Physician's Channel - Mount Sinai New York
Post-viral olfactory loss and parosmia | BMJ Medicine
Panoramica dei disturbi dell'olfatto e del gusto - Problemi di orecchie, naso e gola - Manuale MSD, versione per i pazienti
RACGP - COVID 19 related anosmia
Pearls from your Peers: Post-COVID Smell Loss | AAO-HNS Bulletin
RACGP - COVID 19 related anosmia
Early recovery following new onset anosmia during the COVID-19 pandemic – an observational cohort study | Journal of Otolaryngology - Head & Neck Surgery | Full Text
Running a post-COVID smell clinic | ENT & Audiology News
Alpha-lipoic acid does not improve olfactory training results in olfactory loss due to COVID-19: a double-blind randomized trial | Brazilian Journal of Otorhinolaryngology
Pathophysiology and possible treatments for olfactory-gustatory disorders in patients affected by COVID-19 - ScienceDirect
Anosmia in COVID-19: A Bumpy Road to Establishing a Cellular Mechanism | ACS Chemical Neuroscience
Omega 3 Fatty Acids and COVID-19: A Comprehensive Review
Pathophysiology and possible treatments for olfactory-gustatory disorders in patients affected by COVID-19 - ScienceDirect
Taste and Smell Disorders in COVID-19 Patients: Role of Interleukin-6 | ACS Chemical Neuroscience
